|View printer-friendly version|
|May 13, 2009 5:03 p.m.|
|Teva Announces Presentations At Bank Conferences|
|Jerusalem, Israel, May 13, 2009 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the Bank of America and Merrill Lynch 2009 Healthcare Conference with William Marth, President and Chief Executive Officer, Teva North America presenting on Thursday, May 14, 2009. Eyal Desheh, Chief Financial Officer, will present on Monday, May 18, 2009 at the Deutsche Bank Securities 34th Annual Healthcare Conference.|
What: Teva Presentation at the Bank of America and Merrill Lynch 2009 Healthcare Conference
Teva Presentation at the Deutsche Bank Securities 34th Annual Healthcare Conference
Who: William Marth, President and Chief Executive Officer, Teva North America
Eyal Desheh, Chief Financial Officer
When: Thursday, May 14, 2009 at 10:40 a.m. ET
Monday, May 18, 2009 at 12:00 p.m. ET
Where: http://www.veracast.com/webcasts/bas/healthcare09/id35305192.cfm or http://www.tevapharm.com/financial/
http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=TEVA&item_id=2176080 or http://www.tevapharm.com/financial/
How: Live over the Internet -- log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website.
Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the world's leading generic pharmaceutical company. The Company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients, as well as animal health pharmaceutical products. Over 80 percent of Teva's sales are in North America and Europe.